Freedom-to-Operate Risks Rise in CRISPR & Gene Therapy Patents
Navigating IP Minefields in the Next Wave of Genetic Medicine Introduction: Innovation Meets the Patent Wall CRISPR gene editing and advanced gene therapies are no
Latest News
White Hydrogen Enters Pilot Phase: Technology Maturity & Policy Support in Focus
📌 Executive Summary (Intro) Expanding into global markets opens new growth opportunities—but it also exposes businesses to new infringement risks. A product that is safe
Japan Approves Next-Gen Antimicrobial to Combat Drug-Resistant Sepsis
📌 Executive Summary (Intro) Expanding into global markets opens new growth opportunities—but it also exposes businesses to new infringement risks. A product that is safe
Infringement in Global Markets: What Changes When You Go International?
📌 Executive Summary (Intro) Expanding into global markets opens new growth opportunities—but it also exposes businesses to new infringement risks. A product that is safe
Claim Drafting Strategies: How to Balance Scope and Enforceability
🔹 Introduction: Why Claim Drafting Is the Heart of Patent Value A patent’s real power lies in its claims, not just the invention description Overly
Freedom to Operate (FTO) in Pharma: Why Skipping It Can Cost Millions
In pharma, innovation doesn’t fail only in the lab.Many promising products fail at launch because of patent roadblocks that could have been avoided early. This
Service Robots vs Industrial Robots: Which Is Right for Your Business?
🔹 Introduction Robots are no longer limited to factory floors. From hospitals and hotels to warehouses and retail stores, businesses are adopting robots to improve
The Rise of Immune Engagers: Strategic Implications for Pharma R&D and Licensing
The landscape of oncology is undergoing a profound transformation driven by immunotherapy innovation. Over the past decade, immune checkpoint inhibitors, CAR-T therapies, and antibody-drug conjugates
Beyond Patents: How Universities Can Build Sustainable Revenue Models from IP Assets
Beyond Patents: How Universities Can Build Sustainable Revenue Models from IP Assets For decades, universities have been engines of innovation producing breakthrough research in